by Lora Hammill et al, Daily Clout:

COVID-19 ‘vaccine’ drugs are modified mRNA gene therapy products. So, why did the FDA assign the review and recommendation responsibilities to the Vaccines and Related Biological Products Committee (VRBPAC) instead of the Cellular Tissue and Gene Therapy Advisory Committee (CTGTAC)? CTGTAC was the logical FDA advisory committee for such a product. Yet the FDA insisted on calling the COVID-19 gene therapy injections ‘vaccines’ and assigned them to VRBPAC.